Theophylline and meloxicam-induced Stevens-Johnson syndrome (SJS): rare case reports

IF 0.7 Q4 PHARMACOLOGY & PHARMACY
A. Varghese, N. Kandra, Y. Vangoori, P. Uppala, Upendra Uttaravelli, S. Saibaba, Butti Lavanya, M. Balijepalli
{"title":"Theophylline and meloxicam-induced Stevens-Johnson syndrome (SJS): rare case reports","authors":"A. Varghese, N. Kandra, Y. Vangoori, P. Uppala, Upendra Uttaravelli, S. Saibaba, Butti Lavanya, M. Balijepalli","doi":"10.4103/epj.epj_69_22","DOIUrl":null,"url":null,"abstract":"Stevens-Johnson syndrome (SJS) is an infrequent, multisystemic, fatal, immune-mediated hypersensitivity reaction. SJS may be due to adverse effects of drug intake often characterized by mucocutaneous rash, bullae, and blisters spread over the skin and mucous membranes, hyperpigmentation, puffiness, erosive lesions on lips and face. The most common cause of drug-induced SJS is antimicrobials, followed by NSAIDs, allopurinol, antipsychotics, and antiepileptic drugs. Two cases of atypical SJS presentation associated with the use of theophylline and meloxicam are reported here. Early identification and appropriate corticosteroid therapy might improve the condition. The reason for publishing these case reports is to raise an alarm among our health care fraternity and common man regarding medication-induced SJS, which may be dreadful especially due to theophylline used in bronchial asthma and meloxicam used for osteoarthritis and thereby preventing the expected serious sequelae in SJS.","PeriodicalId":11568,"journal":{"name":"Egyptian Pharmaceutical Journal","volume":"21 1","pages":"531 - 535"},"PeriodicalIF":0.7000,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Egyptian Pharmaceutical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/epj.epj_69_22","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 1

Abstract

Stevens-Johnson syndrome (SJS) is an infrequent, multisystemic, fatal, immune-mediated hypersensitivity reaction. SJS may be due to adverse effects of drug intake often characterized by mucocutaneous rash, bullae, and blisters spread over the skin and mucous membranes, hyperpigmentation, puffiness, erosive lesions on lips and face. The most common cause of drug-induced SJS is antimicrobials, followed by NSAIDs, allopurinol, antipsychotics, and antiepileptic drugs. Two cases of atypical SJS presentation associated with the use of theophylline and meloxicam are reported here. Early identification and appropriate corticosteroid therapy might improve the condition. The reason for publishing these case reports is to raise an alarm among our health care fraternity and common man regarding medication-induced SJS, which may be dreadful especially due to theophylline used in bronchial asthma and meloxicam used for osteoarthritis and thereby preventing the expected serious sequelae in SJS.
茶碱和美洛昔康诱导的Stevens-Johnson综合征(SJS):罕见病例报告
史蒂文斯-约翰逊综合征(SJS)是一种罕见的、多系统的、致命的、免疫介导的超敏反应。SJS可能是由于药物摄入的不良反应引起的,通常表现为皮肤和粘膜上的粘膜皮疹、大疱和水泡、色素沉着过度、浮肿、嘴唇和面部的侵蚀性病变。药物诱导SJS最常见的原因是抗菌药物,其次是非甾体抗炎药、别嘌呤醇、抗精神病药物和抗癫痫药物。本文报告了两例与茶碱和美洛昔康使用相关的非典型SJS表现。早期识别和适当的皮质类固醇治疗可能会改善病情。发表这些病例报告的原因是为了在我们的卫生保健兄弟会和普通人中引起对药物诱导的SJS的警觉,这可能是可怕的,特别是由于茶碱用于支气管哮喘和美洛昔康用于骨关节炎,从而预防预期的SJS严重后遗症。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Egyptian Pharmaceutical Journal
Egyptian Pharmaceutical Journal PHARMACOLOGY & PHARMACY-
CiteScore
1.10
自引率
0.00%
发文量
37
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信